After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest ...

In its upcoming report, Edwards Lifesciences (EW) is predicted by Wall Street analysts to post quarterly earnings of $0.55 per share, reflecting a decline of 14.1% compared to the same period last ...

Watkins brings more than 27 years of experience to Fieldfisher, with a focus on cross-border mergers and acquisitions, PE ...

The stock's rise snapped a three-day losing streak.

Learn more about whether Edwards Lifesciences Corporation or Stryker Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Matthew Edwards joined Brown Rudnick as a transactions partner in its global life sciences practice group in London, the firm ...

U.S. medical device maker Becton Dickinson is considering a potential separation of its life sciences unit at a valuation of ...

Edwards Lifesciences Co. (NYSE:EW – Get Free Report) has been given a consensus rating of “Hold” by the twenty-six ratings firms that are presently covering the stock, Marketbeat Ratings reports. One ...

Stifel Nicolaus upgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a hold rating to a buy rating in a report published on Thursday morning, Ratings reports. The firm currently has ...